A Phase I Trial of LY2510924, a CXCR4 Peptide Antagonist, in Patients with Advanced Cancer

Title
A Phase I Trial of LY2510924, a CXCR4 Peptide Antagonist, in Patients with Advanced Cancer
Authors
Keywords
-
Journal
CLINICAL CANCER RESEARCH
Volume 20, Issue 13, Pages 3581-3588
Publisher
American Association for Cancer Research (AACR)
Online
2014-04-12
DOI
10.1158/1078-0432.ccr-13-2686

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search